Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Microbiology Part 2 > Lec 31 Viral Hepatitis > Flashcards

Lec 31 Viral Hepatitis Flashcards

You may prefer our related Brainscape-certified flashcards:
Biology 101 flashcards
1
Q

What is viral hepatitis?

A

inflammation of liver caused by a virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are symptoms of viral hepatitis?

A
  • jaundice [yellow skin/eyes]
  • fatigue
  • ab pain
  • loss of appetite
  • nausea
  • vomit
  • diarrhea
  • low fever
  • headache

or may not have symptoms!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What virus/name for hep A?

A

virus: picornavirus
name: infectious hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What virus/name for hep B?

A

virus: hepadnavirus
name: serum hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What virus/name for hep C?

A

virus: flaviviridae
name: Non-A, non-B hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What virus/name for hep d?

A

virus: deltavirus
name: delta agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What virus/name for hep E?

A

virus: hepevirus
name: enteric non-A, non-B hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are similarities between the Hepatitis viruses?

A
  • similar symptoms
  • liver tropism and infect hepatocytes
  • primary/exclusively associated with liver disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hep A: onset, severity, chronicity?

A

onset: abrupt
severity: mild
chronic: no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hep B: onset, severity, chronicity?

A

onset: slow
severity: occasionally severe
chronic: yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hep C: onset, severity, chronicity?

A

onset: slow
severity: usually subclinical
chronic: yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hep d: onset, severity, chronicity?

A

onset: abrupt
severity: occasionally severe
chronic: yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hep E: onset, severity, chronicity?

A

onset: abrupt
severity: severe in pregnant
chronic: no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hep A: Is there a vaccine? treatment?

A

vaccine: children > 1 yr, travelers, at risk
treat: none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hep B: Is there a vaccine? treatment?

A

vaccine: for infants and adults at risk
treat: yes, rarely cures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hep C: Is there a vaccine? treatment?

A

vaccine: none
treat: yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hep d: Is there a vaccine? treatment?

A

vaccine: none
treat: none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hep E: Is there a vaccine? treatment?

A

vaccine: none
treat: none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Who gets Hep B?

A
  • common in high risk groups –> IV drug users
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are viral characteristics of HBV [including family + genus]?

A

family: hepadnaviridae
genus: orthohepadnavirus
- spherical particle
- enveloped
- partially double stranded
- circular DNA
- small genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How does replication of HBV occur?

A

via RNA intermediate by reverse transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are possible outcomes of acute HBV infection?

A

if have effective T cell response: get subclinical disease or acute hepatitis and then recover [<1% get fulminant hepatitis and die]

if limited T cell response: get persistant infection leading to recovery or chronic hepatitis and then cirrhosis

– limited response more likely in perinatally infected infants and immunocompromised

23
Q

What is immune response to acut hep B? How does this differ in chronic Heb B

A
  • production anti-HBsAg, anti-HBeAg, anti-HBc-Ag

- in chronic hep B no anti-HBs

24
Q

What are levels of anti-HBc Igm, Anti-HBc IgG, HBsAg, and Anti-HBs in resolved acute HBV?

A

anti HBc IgM: negative
anti HBc IgG: pos
HBsAg: neg
Anti-HBs: pos

25
Q

What are levels of anti-HBc Igm, Anti-HBc IgG, HBsAg, and Anti-HBs in chronic HBV?

A

anti HBc IgM: neg
anti HBc IgG: pos
HBsAg: pos
Anti-HBs: neg

26
Q

What is virus theory of mech for induction of hepatocellular carcinoma?

A
  • viral products act as oncogenes

- get integration of viral genome and disruption of cellular gene expression

27
Q

What is indirect/nodular cirrhosis theory of mech for induction of hepatocellular carcinoma?

A
  • chronic hepatic injury and repair processes lead to genetic changes causing uncontrolled growth
28
Q

What are the 2 treatments for chronic HBV?

A
  • pegylated interferon alpha = antiviral cytokine

- reverse transcriptase inhibitors [almivudine, entecavir, tenofovir]

29
Q

Who do you treat for chornic HBV?

A
  • pts positive for HBsAg for > 6 mos
  • high HBV DNA levels
  • high ALT
  • evidence of liver disease
30
Q

What is mech of lamivudine? administration? resistance? cost?

A

mech: nucleoside analog reverse transcriptase inhibitor, similar to deoxyC, terminates chain
admin: oral
resistance: high levels
cost: low

31
Q

What is mech of entecavir? administration? resistance? cost?

A

mech: nucleoside analog reverse transcriptase inhibitor, similar to deoxyG, terminates chain
admin: oral
resistance: low levels, cross-resistant with lamivudine
cost: high

32
Q

What is mech of tenofovir? administration? resistance? cost?

A

mech: nucleoside analog reverse transcriptase inhibitor, similar to deoxyA, terminates chain
admin: oral
resistance: none, use in pts with lamivudine or entecavir resistance
cost: intermediate

33
Q

What are vaccines for HBV?

A
  • early ones used HBsAg
  • current uses non-glycosylated HBsAg in yeast and adjuvant alum
  • requires multiple immunization, failure common in HIV
  • can give along with hep B Ig in neonates born to infected mothers just after birth to prevent infection
34
Q

What is hep delta virus? who gets it? symptoms?

A
  • subviral satellite virus –> needs HBV to provide envelope proteins for assembly
  • only infects HBV+
  • increases incidence of active hepatitis, cirrhosis, hepatocellular carcinoma in chronic HBV and likelihood of death from fulminant hep
35
Q

What are top sources of HCV infection?

A
  • IV drug use
  • sexual
  • transfusion
36
Q

What are viral properties of HCV including family/genus?

A

family: flaviviridae
genus: hepacivirus
- single strand
- pos sense RNA
- high mutation rate [error-prone RNA pol]
- exists to quasispecies

37
Q

What is significance of HCV as a quasispecies?

A
  • allows to escape from immune response

- often resistant to treatment

38
Q

What are outcomes of HCV infection?

A

acute –> 80% get chronic

  • -> 35% get stable chronic
  • -> 65% slowly progressive with some symptoms –> leads to cirrhosis in 30% –> can get slowly progressive cirrhosis or liver failure/cancer/death
39
Q

What is mech of ineffective cellular immune response to HCV?

A
  • co infection with HIV
  • viral evasion of innate immune response
  • impaired NK cell, dendritic cell function
  • glycosylated envelope proteins protect against Ab mediated neutralization
  • sequence variations allows immune escape for T & B cell
40
Q

How do you diagnose/assess HCV infection?

A
  • serology: look for antibodies to core, NS3 and NS5 detected within 6-8 wks of exposure
  • RT-PCR: measure viral load in serum, genotype via sequence
  • liver biopsy: assess stage of liver injury
41
Q

how do you treat HCV?

A

indirect antivral:
- PEG-interferon-alpha + ribavirin

direct acting

  • telaprevir/bocoprevir [protease inhibitors] + PEG-IFN-a + ribavirin
  • sofusbuvir [polymerase inhibit]
  • simepravir [protease inhibit]
42
Q

What are downsides of telpravir/bocoprevir as treatment for HCV?

A
  • only targets genotype 1

- get anemia, rash, interforon still need, 8 hr dosing

43
Q

What are downsides of sofubuvir as treatment for HCV?

A
  • no side effects

- interacts with P-glycoprotein substrate, avoid P-gp inducers [rifampin, st johns wort]

44
Q

What are downsides of simepravir as treatment for HCV?

A

side effect: photosensitivity/rash

drug interactions: CYP3A4 inducers/inhibitors

45
Q

How is Hep A transmitted?

A

person to person via fecal-oral route

46
Q

What are clinical features of hep A [time frame, complications]

A
  • self limited [3 wks]

- can profress to fulminant hep failure in pts with underlying liver diesase [HBV or HCV]

47
Q

How do you diagnose HAV?

A
  • symptoms of acute viral hepatitis

- detection of HAV-specific IgM anitbody in acute-phase serum

48
Q

What is treatment for HAV?

A

supportive

49
Q

How do you prevent HAV?

A

vaccination [recommend at under 1 yr old]

50
Q

What is typical course of acute hep A?

A
  • jaundice symptoms coincide with peak ALT, then ALT lower, IgM Anti-HAV lowers, Anti-HAV stays high
51
Q

What is clinical presentation of Hep E? Who gets it?

A
  • similar clinical to HAV
  • found in developing countries with fecal contamination of drinking water
  • self limited followed by recovery
  • chronic infection does not occur
  • occassionaly get fulminant hep in pregnant women
52
Q

How is hep E transmitted?

A

fecal oral = fecal contamination of drinking water in developing countries

53
Q

What does it mean if you have negative Anit-HBc IgM, anti-HBc IgG, and HBsAg by positive Anti-HBs for HBV?

A

means you were not infected but had a prior acute vaccination for HBV

Microbiology Part 2 (30 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions